Updated Jul 16, 2026
WEINSTEIN ROBERT has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Robert Weinstein is a corporate executive known for his roles as Chief Financial Officer and Director at PharmaCyte Biotech, Inc. and other companies. He has been involved in SEC filings related to his positions but does not have significant public recognition.
| Role | Chief Financial Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-03 | XWEL | XWELL, Inc. | A — Grant or award | 100.0K | $0.00 | |
| 2025-12-12 | PMCB | PharmaCyte Biotech, Inc. | F — Tax withholding / forfeiture | 33.8K | $1.02 | $34K |
| 2025-12-12 | PMCB | PharmaCyte Biotech, Inc. | A — Grant or award | 75.0K | $0.00 | |
| 2025-08-06 | TAOX | TAO Synergies Inc. | F — Tax withholding / forfeiture | 4.0K | $7.23 | $29K |
| 2025-08-06 | TAOX | TAO Synergies Inc. | A — Grant or award | 10.0K | $0.00 | |
| 2025-06-30 | TAOX | TAO Synergies Inc. | F — Tax withholding / forfeiture | 6.2K | $7.85 | $48K |
| 2025-06-30 | TAOX | TAO Synergies Inc. | A — Grant or award | 15.4K | $0.00 | |
| 2025-06-02 | XWEL | XWELL, Inc. | A — Grant or award | 107.4K | — |
Robert Weinstein is a corporate executive known for his roles as Chief Financial Officer and Director at PharmaCyte Biotech, Inc. and other companies. He has been involved in SEC filings related to his positions but does not have significant public recognition.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live WEINSTEIN ROBERT profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.